跳至主要内容
临床试验/ACTRN12621001080819
ACTRN12621001080819尚未招募未知

A randomised controlled trial of the effect high-flow nasal oxygen (HFNO) vs standard oxygen therapy on post-surgical oxygen partial pressure in patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) under conscious sedation

The Alfred0 个研究点目标入组 60 人开始时间: 2021年8月16日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Inclusion Criteria
  • Informed consent available;
  • Adult patients (> 18 years) with signed informed consent with body mass index greater than or equal to 35 kg/m2;
  • Elective TAVI procedure; and
  • Patients capable of performing a walk test and spirometry

排除标准

  • Exclusion Criteria
  • No informed consent available;
  • Contraindication to HFNO such as nasal septal defect;
  • Uncooperative patient; and
  • Need for intubation / conversion to GA during procedure.

研究者

发起方
The Alfred

相似试验